Resistance mutations of hepatitis B virus in entecavir‐refractory patients

The emergence of resistance mutations in the reverse transcriptase gene of hepatitis B virus (HBV) is associated with treatment failure. Entecavir (ETV) is one of the most potent anti‐HBV reagents; it has a very low resistance rate and is used as the first‐line treatment for chronic hepatitis B. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Norie, Sugiyama, Ryuichi, Nitta, Sayuri, Murayama, Asako, Kobayashi, Minoru, Okuse, Chiaki, Suzuki, Michihiro, Yasuda, Kiyomi, Yotsuyanagi, Hiroshi, Moriya, Kyoji, Koike, Kazuhiko, Wakita, Takaji, Kato, Takanobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721430/
https://www.ncbi.nlm.nih.gov/pubmed/29404449
http://dx.doi.org/10.1002/hep4.1022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721430/
https://www.ncbi.nlm.nih.gov/pubmed/29404449
http://dx.doi.org/10.1002/hep4.1022

Ejemplares similares